K(ATP) channel blocking actions of quaternary ions play no role in their antiproliferative action on mouse leukaemia and rat vascular smooth muscle cells in vitro

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 12, 1998, Pages 992-998

  Piekarska, Anna E ^a   Webster, Lorraine ^b   Saltis, John ^c   McPherson, Grant A ^a  

^a MONASH UNIVERSITY   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Cisplatin; Dequalinium chloride; Glibenclamide; K(ATP) channels; Levcromakalim; Mouse L1210 leukaemia cells; Quaternary ions; Rat smooth muscle cells; Rhodamine 123; Tetraphenylboron; Tetraphenylphosphonium

Indexed keywords

CISPLATIN; DEQUALINIUM; GLIBENCLAMIDE; LEMAKALIM; POTASSIUM CHANNEL; RHODAMINE 123; TETRAPHENYLBORON; TETRAPHENYLPHOSPHONIUM; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; CATION; ORGANOPHOSPHORUS COMPOUND; POTASSIUM CHANNEL BLOCKING AGENT; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CHANNEL GATING; CORONARY ARTERY; DOSE RESPONSE; DRUG POTENCY; GROWTH INHIBITION; LEUKEMIA L 1210; MOUSE; NONHUMAN; RAT; SWINE; VASCULAR SMOOTH MUSCLE; ANIMAL; AORTA; CELL CULTURE; CELL DIVISION; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECT; IN VITRO STUDY; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PHYSIOLOGY;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS; AORTA; CELL DIVISION; CELLS, CULTURED; CISPLATIN; CORONARY VESSELS; DEQUALINIUM; LEUKEMIA L1210; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; ONIUM COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; POTASSIUM CHANNEL BLOCKERS; RATS; RHODAMINE 123; SWINE; TETRAPHENYLBORATE; VASOCONSTRICTOR AGENTS;

EID: 0032217199     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02172.x     Document Type: Article

References (19)

1. 2+ release. Cell. Signal. 1993; 5: 803-9.
2. Rideout D, Bustamante A, Patel J. Mechanism of inhibition of FaDu hypopharyngeal carcinoma cell growth by tetraphenylphosphonium chloride. Int. J. Cancer. 1994; 57: 247-53.
3. Davis S, Weiss MJ, Wong JR, Lampidis TJ, Chen LB. Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J. Biol. Chem. 1985; 260: 13 844-50.
4. Lampidis TJ, Hasin Y, Weiss MJ, Chen LB. Selective killing of carcinoma cells in vitro by lipophilic cationic compounds: A cellular basis. Biomed. Pharmacother. 1985; 39: 220-6.
5. + channel opener, levcromakalim, in vascular smooth muscle. Br. J. Pharmacol. 1994; 112: 1223-9.
6. Webster LK, Deacon GB, Buxton DP et al. cis-Bis (pyridine)-platinum (II) organoamides with unexpected growth inhibition properties and antitumor activity. J. Med. Chem. 1992; 35: 3349-53.
7. Saltis J, Bobik A. Vascular smooth muscle growth in genetic hypertension: Evidence for multiple abnormalities in growth regulatory pathways. J. Hypertens. 1992; 10: 635-43.
8. Jenkinson DH. How we describe competitive antagonists: Three questions of usage. Trends Pharmacol. Sci. 1991; 12: 53-4.
9. Chen LB. Mitochondrial membrane potential in living cells. Annu. Rev. Cell. Biol. 1988; 4: 155-81.
10. Piekarska AE, McPherson GA. Structure-activity relationship of quaternary ion antagonism of levcromakalim-induced realxation in pig coronary artery. Eur. J.Pharmacol. 1997; 322: 37-44.
11. ATP channels. Clin. Exp. Pharm. Physiol. 1994; 21: 583-97.
12. Zhang H, Bolton TB, Piekarska AE, McPherson GA. The electrophysiological effects of tetraphenylphosphonium on vascular smooth muscle. Eur. J. Pharmacol. 1998: 347: 119-23.
13. Haydon DA, Hladky SB. Ion transport across thin lipid membranes: A critical discussion of mechanisms in selected systems. Q. Rev. Biophys. 1972; 5: 187-282.
14. Saito S, Murakami Y, Miyauchi S, Kamo N. Measurement of plasma membrane potential in isolated rat hepatocytes using the lipophilic cation, tetraphenylphosphonium: Correction of probe intracellular binding and mitochondrial accumulation. Biochim. Biophys. Acta 1992; 1111: 221-30.
15. Dubois JM, Rouzaire-Dubois B. Role of potassium channels in mitogenesis. Prog. Biophys. Mol. Biol. 1993; 59: 1-21.
16. + channels in cell proliferation. News Physiol. Sci. 1994; 9: 105-10.
17. Woodfork KA, Wonderlin WF, Peterson VA, Strobl JS. Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture. J. Cell. Physiol. 1995; 162: 163-71.
18. 2 receptor in dog coronary artery. Br. J. Pharmacol. 1990; 100: 375-8.
19. Lee YS, Sayeed MM, Wurster RD. In vitro antitumor activity of cromakalim in human brain tumor cells. Pharmacology 1994; 49: 69-74.